Open-label safety study of TMC114 [darunavir] in combination with low dose RTV and other ARVs in highly experienced HIV-1 infected patients with limited or no treatment options

Trial Profile

Open-label safety study of TMC114 [darunavir] in combination with low dose RTV and other ARVs in highly experienced HIV-1 infected patients with limited or no treatment options

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Darunavir; Ritonavir
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Most Recent Events

    • 03 Nov 2009 Actual number of patients (260) added from ClinicalTrials.gov record.
    • 26 Jan 2008 Status changed from in progress to completed (source: ClinicalTrials.gov).
    • 16 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top